nach oben

Erschienen in:

2019 | OriginalPaper | Buchkapitel

11. Kindliche Knochenmarkerkrankungen

verfasst von : Prof. Dr. Stefan Gattenlöhner

Erschienen in: Pathologie

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Kindliche Knochenmarkerkrankungen werden in nicht-neoplastische und neoplastische Formen eingeteilt. Bei den nicht-neoplastischen Erkrankungen werden Veränderungen, die präferentiell eine hämatologische Bildungsreihe betreffen und im peripheren Blut entweder mit einer verminderten oder erhöhten Zellzahl einhergehen von syndromalen Erkrankungen mit progredientem Knochenmarkversagen unterschieden. Neoplastische Knochenmarkerkrankungen werden in Anlehnung an die beim Erwachsenen definierten Formen klassifiziert, weisen jedoch nach Art, genetischen Befunden und Prognose charakteristische Unterschiede auf. Die in dieser Altersgruppe zahlreichen besonderen Entitäten werden umfassend dargestellt und die Bedeutung der bioptischen Untersuchung im Krankheitsverlauf herausgestellt.

Alexander FE, Patheal SL et al (2001) Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 61:2542–2546PubMed

Alter BP (2005) Fanconi’s anemia, transplantation, and cancer. Pediatr Transplant 9(Suppl 7):81–86CrossRef

Aminoff M, Carter JE et al (1999) Mutations in CUBN, encoding the intrinsic factor-vitamin B12 receptor, cubilin, cause hereditary megaloblastic anaemia 1. Nat Genet 21:309–313CrossRef

Ancliff PJ (2003) Congenital neutropenia. Blood Rev 17:209–216CrossRef

Anil S, Beena VT et al (1994) Oral squamous cell carcinoma in a case of dyskeratosis congenita. Ann Dent 53:15–18PubMed

Aprikyan AA, Liles WC et al (2002) Mutant elastase in pathogenesis of cyclic and severe congenital neutropenia. J Pediatr Hematol Oncol 24:784–786CrossRef

Aprikyan AA, Liles WC et al (2000) Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors. Blood 95:320–327PubMed

Ballew BJ, Savage SA (2013) Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol 6:327–337CrossRef

Ballmaier M, Germeshausen M (2011) Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment. Semin Thromb Hemost 37:673–681CrossRefPubMed

10.

Barrios N, Kirkpatrick D et al (1991) Bone marrow transplant in Shwachman Diamond syndrome. Br J Haematol 79:337–338CrossRef

11.

Bene MC, Castoldi G et al (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9:1783–1786PubMed

12.

Boocock GR, Morrison JA et al (2003) Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 33:97–101CrossRef

13.

Bottom KS, Adams DM et al (1997) Trilineage hematopoietic toxicity associated with valproic acid therapy. J Pediatr Hematol Oncol 19:73–76CrossRef

14.

Boxer LA, Stein S et al (2006) Strong evidence for autosomal dominant inheritance of severe congenital neutropenia associated with ELA2 mutations. J Pediatr 148:633–636CrossRef

15.

Brink DS (2006) Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome. Adv Anat Pathol 13:256–262CrossRef

16.

Bruin MC, von dem Borne AE et al (1999) Neutrophil antibody specificity in different types of childhood autoimmune neutropenia. Blood 94:1797–1802PubMed

17.

Campo E, Swerdlow SH et al (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 117:5019–5032CrossRefPubMed

18.

Crispino JD (2005) GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia. Pediatr Blood Cancer 44:40–44CrossRef

19.

Curtis BR, Reno C et al (2005) Neonatal alloimmune neutropenia attributed to maternal immunoglobulin G antibodies against the neutrophil alloantigen HNA-1c (SH): a report of five cases. Transfusion 45:1308–1313CrossRef

20.

Dame C, Sutor AH (2005) Primary and secondary thrombocytosis in childhood. Br J Haematol 129:165–177CrossRef

21.

Dokal I (2000) Dyskeratosis congenita in all its forms. Br J Haematol 110:768–779CrossRef

22.

Drachman JG (2004) Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood 103:390–398CrossRef

23.

Drachtman RA, Alter BP (1995) Dyskeratosis congenita. Dermatol Clin 13:33–39CrossRef

24.

Draptchinskaia N, Gustavsson P et al (1999) The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet 21:169–175CrossRef

25.

Dror Y, Sung L (2004) Update on childhood neutropenia: molecular and clinical advances. Hematol Oncol Clin North Am 18:1439–1458CrossRef

26.

Etzioni A, Sturla L et al (2002) Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG) IIc founder effect and genotype/phenotype correlation. Am J Med Genet 110:131–135CrossRef

27.

Fisch P, Handgretinger R et al (2000) Pure red cell aplasia. Br J Haematol 111:1010–1022CrossRef

28.

Furuyama K, Harigae H et al (2003) Late-onset X-linked sideroblastic anemia following hemodialysis. Blood 101:4623–4624CrossRef

29.

Fyfe JC, Madsen M et al (2004) The functional cobalamin (vitamin B12)-intrinsic factor receptor is a novel complex of cubilin and amnionless. Blood 103:1573–1579CrossRef

30.

Glaubach T, Robinson LJ et al (2014) Pediatric myelodysplastic syndromes: they do exist! J Pediatr Hematol Oncol 36:1–7CrossRef

31.

Go RS (2005) Idiopathic cyclic thrombocytopenia. Blood Rev 19:53–59CrossRef

32.

Gordeuk VR, Sergueeva AI et al (2004) Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood 103:3924–3932CrossRef

33.

Hahn CN, Chong CE et al (2011) Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 43:1012–1017CrossRefPubMed

34.

Hasle H, Wadsworth LD et al (1999) A population-based study of childhood myelodysplastic syndrome in British Columbia, Canada. Br J Haematol 106:1027–1032CrossRef

35.

Heimpel H, Anselstetter V et al (2003) Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Blood 102:4576–4581CrossRef

36.

Hsu AP, Sampaio EP et al (2011) Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118:2653–2655CrossRefPubMed

37.

Huff JD, Keung YK et al (2007) Copper deficiency causes reversible myelodysplasia. Am J Hematol 82:625–630CrossRef

38.

Hunger SP, Mullighan CG (2015) Acute lymphoblastic leukemia in children. N Engl J Med 373:1541–1552CrossRef

39.

Ihara K, Ishii E et al (1999) Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proc Natl Acad Sci U S A 96:3132–3136CrossRefPubMed

40.

Inaba H, Greaves M et al (2013) Acute lymphoblastic leukaemia. Lancet 381:1943–1955CrossRefPubMed

41.

Introne W, Boissy RE et al (1999) Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Mol Genet Metab 68:283–303CrossRefPubMed

42.

Kee Y, D’Andrea AD (2012) Molecular pathogenesis and clinical management of Fanconi anemia. J Clin Invest 122:3799–3806CrossRefPubMed

43.

Kralovics R, Skoda RC (2005) Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders. Blood Rev 19:1–13CrossRefPubMed

44.

Kunze K, Gamerdinger U et al (2014) Detection of an activated JAK3 variant and a Xq26.3 microdeletion causing loss of PHF6 and miR-424 expression in myelodysplastic syndromes by combined targeted next generation sequencing and SNP array analysis. Pathol Res Pract 210:369–376CrossRefPubMed

45.

Landowski M, O’Donohue MF et al (2013) Novel deletion of RPL15 identified by array-comparative genomic hybridization in Diamond-Blackfan anemia. Hum Genet 132:1265–1274CrossRefPubMed

46.

Liljeholm M, Irvine AF et al (2013) Congenital dyserythropoietic anemia type III (CDA III) is caused by a mutation in kinesin family member, KIF23. Blood 121:4791–4799CrossRefPubMed

47.

Locatelli F, Niemeyer CM (2015) How I treat juvenile myelomonocytic leukemia. Blood 125:1083–1090CrossRefPubMed

48.

Luna-Fineman S, Shannon KM et al (1999) Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood 93:459–466PubMed

49.

Masetti R, Vendemini F et al (2015) Acute myeloid leukemia in infants: biology and treatment. Front Pediatr 3:37CrossRefPubMed

50.

Mason PJ, Bessler M (2011) The genetics of dyskeratosis congenita. Cancer Genet 204:635–645CrossRefPubMed

51.

Michaud J, Wu F et al (2002) In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Blood 99:1364–1372CrossRef

52.

Mori H, Colman SM et al (2002) Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci U S A 99:8242–8247CrossRefPubMed

53.

Mullighan CG, Goorha S et al (2007) Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446:758–764CrossRef

54.

Niemeyer CM, Arico M et al (1997) Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood 89:3534–3543PubMed

55.

Niemeyer CM, Kratz C (2003) Juvenile myelomonocytic leukemia. Curr Treat Options Oncol 4:203–210CrossRef

56.

Nugent DJ (2002) Childhood immune thrombocytopenic purpura. Blood Rev 16:27–29CrossRef

57.

Ozyurek E, Cetintas S et al (2006) Complete blood count parameters for healthy, small-for-gestational-age, full-term newborns. Clin Lab Haematol 28:97–104CrossRef

58.

Pasquini R, Carreras J et al (2008) HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. Biol Blood Marrow Transpl 14:1141–1147CrossRef

59.

Perkins SL (2004) Pediatric red cell disorders and pure red cell aplasia. Am J Clin Pathol 122(Suppl):S70–S86PubMed

60.

Renella R, Roberts NA et al (2011) Codanin-1 mutations in congenital dyserythropoietic anemia type 1 affect HP1α localization in erythroblasts. Blood 117:6928–6938CrossRef

61.

Sachs UJ, Kroll H et al (2003) Bernard-Soulier syndrome due to the homozygous Asn-45Ser mutation in GPIX: an unexpected, frequent finding in Germany. Br J Haematol 123:127–131CrossRef

62.

Schwarz K, Iolascon A et al (2009) Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet 41:936–940CrossRef

63.

Smith OP (2002) Shwachman-Diamond syndrome. Semin Hematol 39:95–102CrossRef

64.

Soulier J, Leblanc T et al (2005) Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. Blood 105:1329–1336CrossRef

65.

Tartaglia M, Niemeyer CM et al (2003) Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 34:148–150CrossRef

66.

Tefferi A (2001) Chronic myeloid disorders: classification and treatment overview. Semin Hematol 38(Suppl 2):1–4CrossRef

67.

Tischkowitz M, Dokal I (2004) Fanconi anaemia and leukaemia – clinical and molecular aspects. Br J Haematol 126:176–191CrossRef

68.

Van Maerken T, Hunninck K et al (2004) Familial and congenital polycythemias: a diagnostic approach. J Pediatr Hematol Oncol 26:407–416CrossRef

69.

Wickramasinghe SN, Wood WG (2005) Advances in the understanding of the congenital dyserythropoietic anaemias. Br J Haematol 131:431–446CrossRef

70.

Willig TN, Gazda H et al (2000) Diamond-Blackfan anemia. Curr Opin Hematol 7:85–94CrossRef

71.

Yetgin S, Ozen S et al (1997) Myelodysplastic features in juvenile rheumatoid arthritis. Am J Hematol 54:166–169CrossRef

72.

Zarzour W, Kleta R et al (2005) Two novel CHS1 (LYST) mutations: clinical correlations in an infant with Chediak-Higashi syndrome. Mol Genet Metab 85:125–132CrossRef

Titel: Kindliche Knochenmarkerkrankungen
verfasst von: Prof. Dr. Stefan Gattenlöhner
Verlag: Springer Berlin Heidelberg
Buch: Pathologie
Print ISBN: 978-3-540-85183-7

Electronic ISBN: 978-3-540-85184-4

Copyright-Jahr: 2019
DOI: https://doi.org/10.1007/978-3-540-85184-4_11

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

11. Kindliche Knochenmarkerkrankungen

Zusammenfassung

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren